Value-buying on reports of Sun Pharmaceutical Industries acquiring troubled Ranbaxy Laboratories, in an all-stock transaction with a total equity value of USD 3.2 billion, led smart gains in healthcare segment.
The 30-share index Sensex resumed lower at 22,355.56 and declined further to 22,319.73 later rebounded to 22,481.62 before quoting 22,434.95 at 1000hrs, showing a gain of 75.45 points or 0.34 per cent from its last close.
The NSE 50-share Nifty also quoting higher by 17.45 points or 0.26 per cent to 6,711.80 at 1000 hours.
Most Asian stocks fell in their early trade. Key benchmark indices in South Korea, Hong Kong, Singapore and Japan were down 0.22 per cent to 1.34 per cent. Markets in mainland China and Thailand are closed for a holiday.
Meanwhile, Foreign Institutional Investors (FIIs) bought shares worth net Rs 232.46 crore on last Friday, as per provisional data from the stock exchanges.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
